• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用半自动图像分析技术从患者血清中检测细胞培养中的丙型肝炎病毒感染

Detection of Hepatitis C Virus Infection from Patient Sera in Cell Culture Using Semi-Automated Image Analysis.

作者信息

Schäfer Noemi, Rothhaar Paul, Heuss Christian, Neumann-Haefelin Christoph, Thimme Robert, Dietz Julia, Sarrazin Christoph, Schnitzler Paul, Merle Uta, Pérez-Del-Pulgar Sofía, Laketa Vibor, Lohmann Volker

机构信息

Department of Infectious Diseases, Molecular Virology, Section Virus-Host Interactions, Heidelberg University, 69120 Heidelberg, Germany.

Department of Medicine II, Medical Center, Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.

出版信息

Viruses. 2024 Nov 30;16(12):1871. doi: 10.3390/v16121871.

DOI:10.3390/v16121871
PMID:39772180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11680372/
Abstract

The study of hepatitis C virus (HCV) replication in cell culture is mainly based on cloned viral isolates requiring adaptation for efficient replication in Huh7 hepatoma cells. The analysis of wild-type (WT) isolates was enabled by the expression of SEC14L2 and by inhibitors targeting deleterious host factors. Here, we aimed to optimize cell culture models to allow infection with HCV from patient sera. We used Huh7-Lunet cells ectopically expressing SEC14L2, CD81, and a GFP reporter with nuclear translocation upon cleavage by the HCV protease to study HCV replication, combined with a drug-based regimen for stimulation of non-modified wild-type isolates. RT-qPCR-based quantification of HCV infections using patient sera suffered from a high background in the daclatasvir-treated controls. We therefore established an automated image analysis pipeline based on imaging of whole wells and iterative training of a machine learning tool, using nuclear GFP localization as a readout for HCV infection. Upon visual validation of hits assigned by the automated image analysis, the method revealed no background in daclatasvir-treated samples. Thereby, infection events were found for 15 of 34 high titer HCV genotype (gt) 1b sera, revealing a significant correlation between serum titer and successful infection. We further show that transfection of viral RNA extracted from sera can be used in this model as well, albeit with so far limited efficiency. Overall, we generated a robust serum infection assay for gt1b isolates using semi-automated image analysis, which was superior to conventional RT-qPCR-based quantification of viral genomes.

摘要

丙型肝炎病毒(HCV)在细胞培养中的复制研究主要基于克隆的病毒分离株,这些分离株需要经过适应性改造才能在Huh7肝癌细胞中高效复制。通过SEC14L2的表达以及靶向有害宿主因子的抑制剂,实现了对野生型(WT)分离株的分析。在此,我们旨在优化细胞培养模型,以允许用患者血清中的HCV进行感染。我们使用异位表达SEC14L2、CD81和一种在被HCV蛋白酶切割后具有核转位功能的绿色荧光蛋白(GFP)报告基因的Huh7-Lunet细胞来研究HCV复制,并结合基于药物的方案来刺激未修饰的野生型分离株。使用患者血清进行基于逆转录定量聚合酶链反应(RT-qPCR)的HCV感染定量时,在接受达卡他韦治疗的对照中背景较高。因此,我们基于对整个孔的成像以及对机器学习工具的迭代训练,建立了一个自动图像分析流程,使用核GFP定位作为HCV感染的读数。在对自动图像分析分配的命中结果进行视觉验证后,该方法在达卡他韦治疗的样本中未发现背景。由此,在34份高滴度HCV基因1b型(gt1b)血清中的15份中发现了感染事件,揭示了血清滴度与成功感染之间存在显著相关性。我们还进一步表明,从血清中提取的病毒RNA转染也可用于该模型,尽管目前效率有限。总体而言,我们使用半自动图像分析为gt1b分离株生成了一种可靠的血清感染检测方法,该方法优于基于传统RT-qPCR的病毒基因组定量方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/9b5ecbd29075/viruses-16-01871-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/108a3146abdb/viruses-16-01871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/340b3c3b1c03/viruses-16-01871-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/df90fbc1cfa8/viruses-16-01871-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/b08df9db1459/viruses-16-01871-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/13f53fb00235/viruses-16-01871-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/9b5ecbd29075/viruses-16-01871-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/108a3146abdb/viruses-16-01871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/340b3c3b1c03/viruses-16-01871-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/df90fbc1cfa8/viruses-16-01871-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/b08df9db1459/viruses-16-01871-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/13f53fb00235/viruses-16-01871-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb07/11680372/9b5ecbd29075/viruses-16-01871-g006.jpg

相似文献

1
Detection of Hepatitis C Virus Infection from Patient Sera in Cell Culture Using Semi-Automated Image Analysis.使用半自动图像分析技术从患者血清中检测细胞培养中的丙型肝炎病毒感染
Viruses. 2024 Nov 30;16(12):1871. doi: 10.3390/v16121871.
2
Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.达卡他韦通过阻断病毒基因组转移至装配位点来预防丙型肝炎病毒感染。
Gastroenterology. 2017 Mar;152(4):895-907.e14. doi: 10.1053/j.gastro.2016.11.047. Epub 2016 Dec 5.
3
Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.达卡他韦样抑制剂 NS5A 阻断丙型肝炎病毒诱导的膜复制工厂的早期生物发生,独立于 RNA 复制。
Gastroenterology. 2014 Nov;147(5):1094-105.e25. doi: 10.1053/j.gastro.2014.07.019. Epub 2014 Jul 18.
4
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1.达卡他韦与特拉匹韦联合聚乙二醇干扰素α/利巴韦林治疗丙型肝炎病毒1型感染的对比研究
World J Gastroenterol. 2016 Mar 28;22(12):3418-31. doi: 10.3748/wjg.v22.i12.3418.
5
Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation.从肝移植患者中分离的基因型 1b 丙型肝炎病毒分离株的细胞培养复制。
PLoS One. 2011;6(8):e23587. doi: 10.1371/journal.pone.0023587. Epub 2011 Aug 24.
6
SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations.SEC14L2 是一种脂类结合蛋白,可调控 HCV 在不同基因型间和同一基因型内的复制。
J Hepatol. 2019 Apr;70(4):603-614. doi: 10.1016/j.jhep.2018.11.012. Epub 2018 Nov 23.
7
Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.来自基因型 1-7 的 HCV 重组变体对 NS5A 抑制剂的敏感性不同,但对干扰素-α的敏感性没有差异。
Gastroenterology. 2011 Mar;140(3):1032-42. doi: 10.1053/j.gastro.2010.11.036. Epub 2010 Nov 25.
8
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice.两种药物联合治疗方案,包括 NS3/4A 抑制剂、NS5B 抑制剂和非选择性抗病毒药物,对人源化肝脏小鼠的 NS5A-P32 缺失型丙型肝炎病毒有效。
J Gastroenterol. 2019 May;54(5):449-458. doi: 10.1007/s00535-018-01541-x. Epub 2019 Jan 25.
9
SEC14L2 enables pan-genotype HCV replication in cell culture.SEC14L2可使泛基因型丙型肝炎病毒在细胞培养中复制。
Nature. 2015 Aug 27;524(7566):471-5. doi: 10.1038/nature14899. Epub 2015 Aug 12.
10
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.达卡他韦联合索非布韦治疗既往治疗或未经治疗的慢性 HCV 感染。
N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218.

本文引用的文献

1
Therapeutic preparedness: DAA-resistant HCV variants in vitro and in vivo.治疗准备:体外和体内对直接抗病毒药物(DAA)耐药的丙型肝炎病毒(HCV)变异体
Hepatology. 2023 Aug 1;78(2):385-387. doi: 10.1097/HEP.0000000000000405. Epub 2023 Apr 15.
2
Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system.利用新型丙型肝炎病毒 3a 基因型感染性培养系统进行多 DAA 耐药性的特征分析。
Hepatology. 2023 Aug 1;78(2):621-636. doi: 10.1097/HEP.0000000000000353. Epub 2023 Apr 3.
3
Virological characterization of treatment failures and retreatment outcomes in patients infected with "unusual" HCV genotype 1 subtypes.
治疗失败和再治疗结局的患者感染“不常见”的 HCV 基因型 1 亚型的病毒学特征。
Hepatology. 2023 Aug 1;78(2):607-620. doi: 10.1097/HEP.0000000000000379. Epub 2023 Apr 1.
4
A Simple and Effective Method to Concentrate Hepatitis C Virus: Aqueous Two-Phase System Allows Highly Efficient Enrichment of Enveloped Viruses.一种简单有效的丙型肝炎病毒浓缩方法:双水相系统可高效富集包膜病毒。
Viruses. 2022 Sep 8;14(9):1987. doi: 10.3390/v14091987.
5
A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo.一株丙型肝炎病毒 1b 型移植后分离株,在细胞培养中具有高复制效率,并且能够适应体外和体内感染性病毒的产生。
PLoS Pathog. 2022 Jun 28;18(6):e1010472. doi: 10.1371/journal.ppat.1010472. eCollection 2022 Jun.
6
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.用于丙型肝炎病毒疫苗开发的具有抗原多样性的代表性包膜糖蛋白面板。
Gastroenterology. 2022 Feb;162(2):562-574. doi: 10.1053/j.gastro.2021.10.005. Epub 2021 Oct 13.
7
Treatment failure with DAA therapy: Importance of resistance.直接抗病毒药物(DAA)治疗失败:耐药性的重要性
J Hepatol. 2021 Jun;74(6):1472-1482. doi: 10.1016/j.jhep.2021.03.004. Epub 2021 Mar 12.
8
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies.丙型肝炎参考病毒突出了中和抗体的强烈抗体反应和多样化的病毒功能相互作用。
Gut. 2021 Sep;70(9):1734-1745. doi: 10.1136/gutjnl-2020-321190. Epub 2020 Dec 15.
9
ilastik: interactive machine learning for (bio)image analysis.ilastik:用于(生物)图像处理的交互式机器学习。
Nat Methods. 2019 Dec;16(12):1226-1232. doi: 10.1038/s41592-019-0582-9. Epub 2019 Sep 30.
10
Challenges and Promise of a Hepatitis C Virus Vaccine.丙型肝炎病毒疫苗的挑战与前景。
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a036947. doi: 10.1101/cshperspect.a036947.